Bioniq, Leader in AI-Driven Personalized Supplements, Raises $15M Series B
Summary
Bioniqs ability to provide quantifiable before-and-after snapshots of users nutrient needs and optimization progress has been one of the biggest assets in its partnerships with leading health and sports institutions such as Lanserhof and UFC. "Two Options for Personalized Health Optimization Through DataOver the last decade, Bioniq has built the largest proprietary biochemical database of its kind, which leverages blood test data from customers across 5 continents. The AI-powered patent-pending Bioniq algorithm assesses an individuals height, weight, age, lifestyle, and health goals to precisely identify micronutrient imbalances and create a tailor-made supplement formula to help optimize health.Bioniq PRO offers high performers and health enthusiasts the greatest level of personalization and incorporates blood biomarker data into its algorithm, offering users the option to upload existing bloodwork into the system to gain recommendations based upon a global repository of data or book a blood test through Bioniq via a partner lab. "Bioniqs exceptional growth is a testament to its innovative approach for high quality personalized health solutions that professional athletes across the world rely on," said David Kuczek, General Partner at HV Capital. We are excited to support them as they grow and scale their business," said Shravin Mittal, CEO of Unbound.Bioniq, launched in 2019 in London, UK, is the industry leader in offering AI-driven personalized supplements based on blood test data.